ATE189702T1 - Das für das pferde herpes-virus typ 1 glykoprotein d, kodierende gen, sein genprodukt, antikörper und ihre verwendung - Google Patents

Das für das pferde herpes-virus typ 1 glykoprotein d, kodierende gen, sein genprodukt, antikörper und ihre verwendung

Info

Publication number
ATE189702T1
ATE189702T1 AT91917211T AT91917211T ATE189702T1 AT E189702 T1 ATE189702 T1 AT E189702T1 AT 91917211 T AT91917211 T AT 91917211T AT 91917211 T AT91917211 T AT 91917211T AT E189702 T1 ATE189702 T1 AT E189702T1
Authority
AT
Austria
Prior art keywords
antibodies
glycoprotein
gene
ehv
virus type
Prior art date
Application number
AT91917211T
Other languages
English (en)
Inventor
Dennis J O'callaghan
Original Assignee
Res Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Corp Technologies Inc filed Critical Res Corp Technologies Inc
Application granted granted Critical
Publication of ATE189702T1 publication Critical patent/ATE189702T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • C07K16/087—Herpes simplex virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT91917211T 1990-08-01 1991-07-25 Das für das pferde herpes-virus typ 1 glykoprotein d, kodierende gen, sein genprodukt, antikörper und ihre verwendung ATE189702T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56155390A 1990-08-01 1990-08-01
PCT/US1991/005284 WO1992002252A1 (en) 1990-08-01 1991-07-25 The gene encoding equine herpesvirus type 1 glycoprotein d, its gene product, antibodies and their uses

Publications (1)

Publication Number Publication Date
ATE189702T1 true ATE189702T1 (de) 2000-02-15

Family

ID=24242454

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91917211T ATE189702T1 (de) 1990-08-01 1991-07-25 Das für das pferde herpes-virus typ 1 glykoprotein d, kodierende gen, sein genprodukt, antikörper und ihre verwendung

Country Status (8)

Country Link
US (3) US5470718A (de)
EP (1) EP0560776B1 (de)
AT (1) ATE189702T1 (de)
AU (1) AU8545391A (de)
CA (1) CA2088246A1 (de)
DE (1) DE69131984T2 (de)
ES (1) ES2144400T3 (de)
WO (1) WO1992002252A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731188A (en) * 1986-11-20 1998-03-24 Syntro Corporation Recombinant equine herpesviruses
US6248333B1 (en) 1990-04-04 2001-06-19 Health Research Inc. Isolated nucleic acid sequence of equine herpesvirus type 1 glycoprotein D (EHV-1 gD)
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
US5869312A (en) * 1992-01-13 1999-02-09 Syntro Corporation Recombinant swinepox virus
DE69333416D1 (de) * 1992-06-01 2004-03-18 Univ Melbourne Parkville Immunologisches Verfahren für die Detektion von Pferde-Herpesvirus Typ 1 und 4 glycoprotein G Antikörper
US6193983B1 (en) 1992-06-01 2001-02-27 The University Of Melbourne Equine herpesvirus glycoproteins
US6225111B1 (en) 1992-08-07 2001-05-01 Schering Plough Veterinary Corp. Recombinant equine herpesviruses
US6803041B2 (en) * 2001-03-20 2004-10-12 Boehringer Ingelheim Vetmedica, Inc. Equine herpesvirus vaccine
KR102543774B1 (ko) * 2016-09-20 2023-06-19 베링거잉겔하임베트메디카게엠베하 신규한 프로모터
EP3600403A4 (de) * 2017-03-24 2021-01-13 Board of Supervisors of Louisiana State University and Agricultural and Mechanical College Impfstoffstamm vc2 gegen herpes-simplex-virus typ-1 (hsv-1) zur erzeugung einer anti-ehv-1-immunantwort

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110433A (en) * 1976-04-23 1978-08-29 Philips Roxane, Inc. Equine rhinopneumonitis virus

Also Published As

Publication number Publication date
DE69131984T2 (de) 2000-07-06
US5707629A (en) 1998-01-13
WO1992002252A1 (en) 1992-02-20
ES2144400T3 (es) 2000-06-16
AU8545391A (en) 1992-03-02
EP0560776B1 (de) 2000-02-09
DE69131984D1 (de) 2000-03-16
US5795578A (en) 1998-08-18
US5470718A (en) 1995-11-28
EP0560776A4 (en) 1993-12-29
CA2088246A1 (en) 1992-02-02
EP0560776A1 (de) 1993-09-22

Similar Documents

Publication Publication Date Title
CA2121241A1 (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
ZA865277B (en) Virus vaccine
ATE189702T1 (de) Das für das pferde herpes-virus typ 1 glykoprotein d, kodierende gen, sein genprodukt, antikörper und ihre verwendung
ZA923321B (en) Recombinant avipox virus,the culture of cells infected by this virus and vaccines for poultry derived from this virus
DE3587991D1 (de) Rekombinanter herpes simplex gb-gd impfstoff.
ATE105334T1 (de) Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
EP0135841A3 (en) Herpes simplex virus subunit vaccine
ES8801372A1 (es) Un metodo para preparar una vacuna contra el virus de la influenza equina.
IT1252687B (it) Vaccino di poxvirus ricombinante del virus del morbillo
HUP9901005A2 (hu) Herpeszvírusok RFHV/KSHV-alcsaládjába tartozó vírusokból származó glikoprotein-B
ES8504254A1 (es) Procedimiento para obtener un polipeptido
AU605155B2 (en) A structural phosphoprotein (PP 15) of human cytomegalovirus, and the preparation and use thereof
NO964874L (no) Fusjonsglykoprotein fra HCMV og HSV
OA09653A (en) Rubella peptides
ATE160376T1 (de) Dna segment des herpesvirus der marek-krankheit, welches für das glykoprotein ge kodiert
ES2149822T3 (es) Peptidos inmunorreactivos procedentes del virus de epstein-barr.
DK0389286T3 (da) Rekombinant-cytomegalovirus-vaccine
DE69835522D1 (de) Das 74 kilodalton protein der äusseren membran von moraxella catarrhalis
EP0655072A4 (de) Schweine-herpesvirus glykoproteine.
Nakayama et al. Long-term regulation of interferon production by lymphocytes from children inoculated with live measles virus vaccine
DE59710091D1 (de) Von Kaposi-sarkom assoziiertem Herpes-Virus (KSHV, HHV-8) kodiertes Polypeptid und dessen Verwendung in Diagnostik und Therapie
O'Callaghan Vaccine against equine herpesvirus type 1
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
Dundarov et al. Characterization of herpes simplex virus strains isolated from patients with various diseases
O'DONNELL et al. A comparison of T cell responses to glycoprotein B (gB‐1) of herpes simplex virus type 1 and its non‐glycosylated precursor protein, pgB‐1

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee